We are analyzing https://link.springer.com/article/10.1186/s12967-016-0983-9.

Title:
Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer | Journal of Translational Medicine
Description:
Molecular subtypes of breast cancer and presence of tumor-infiltrating immune cells have both been implicated as important predictive and prognostic factors for improved risk stratification and treatment individualization of breast cancer patients. Their association, however, has not been studied in detail. The aim of this study was to evaluate the expression of the T cell markers CD8, FoxP3, CD3 and ζ-chain in molecular subtypes of the invasive margin and tumor center of breast cancer and corresponding sentinel nodes and to deduct prognostic information from these findings. Tumor and sentinel node sections from 177 patients with primary, invasive, unilateral early-stage breast cancer were stained by immunohistochemistry and T-cell phenotypes quantified manually. Clinical data were collected from medical records. The degree of T-cell infiltration and expression of all markers differed significantly among the molecular subtypes, being highest in non-luminal, more aggressive tumors: more T-cell infiltration and higher expression of all markers were associated with hormone receptor negativity, higher proliferation and higher histological grades, but also with larger tumor size. Basal-like tumors, and most remarkably their tumor centers, hosted the highest number of FoxP3+ T-cells with an unfavorable ratio to cytotoxic CD8+ T-cells. T-cell infiltration was generally higher in the invasive margin than the tumor center. A scoring system based on densities of CD3 and CD8 could significantly separate molecular subtypes (p < 0.001). Thus, immunological patterns with functional implications within each subtype are associated with prognostic factors. These findings should be further validated in studies using larger patient populations and longer follow-up.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cancer, tumor, subtypes, breast, pubmed, article, tumors, molecular, tcell, google, scholar, tcells, patients, foxp, luminal, center, prognostic, cas, subtype, infiltration, immune, higher, immunological, cells, invasive, min, markers, margin, phenotypes, density, study, densities, analysis, clinical, significantly, data, expression, response, high, sections, nonluminal, basallike, ratio, lymphocytes, sentinel, lhr, samples, central, number, treatment,

Topics {✒️}

ζ-chain/cd3-ratio positively correlated her2/neu-overexpressing breast cancer cd8+ t-cells markedly differed tumor-infiltrating cd8+ t-cells article download pdf cytotoxic t-cell responses detect pd-l1 expression recruit regulatory t-cells chi square cross-tabulation foxp3+ tumor-infiltrating lymphocytes intrastromal t-cell trapping t-cell phenotypes differs paraffin-embedded tumor blocks cytotoxic cd8+ t-cells densest t-cell infiltration refrigerator-tempered moisture chamber main t-cell area t-cell functionality differs her2/neu-positive subtype her2/neu positive tumors compare long-term survival tumor-infiltrating immune cells immunological tumor-host interactions tumour infiltrating lymphocytes tumor-infiltrating lymphocytes tumor infiltrating lymphocytes her2/neu overexpressing tumors studies found pd-l1 analyzed t-cell phenotypes �tumor-observing’ immune response ζ-chain+ t-cells high t-cell densities luminal her2/neu-overexpressing luminal her2/neu overexpressing her2-negative breast cancer biotinylated horse-anti-mouse higher ζ-chain/cd3 ratio study t-cell infiltration regulatory t-cells water-based assemblage material naturally occurring regulatory her2 positive-subtype compared cytotoxic t-cells full access t-cell receptor node-negative breast cancer xylene-based assemblage-material fewer inter-subtype differences lymphocytic host response her2/neu-status

Questions {❓}

Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer
         description:Molecular subtypes of breast cancer and presence of tumor-infiltrating immune cells have both been implicated as important predictive and prognostic factors for improved risk stratification and treatment individualization of breast cancer patients. Their association, however, has not been studied in detail. The aim of this study was to evaluate the expression of the T cell markers CD8, FoxP3, CD3 and ζ-chain in molecular subtypes of the invasive margin and tumor center of breast cancer and corresponding sentinel nodes and to deduct prognostic information from these findings. Tumor and sentinel node sections from 177 patients with primary, invasive, unilateral early-stage breast cancer were stained by immunohistochemistry and T-cell phenotypes quantified manually. Clinical data were collected from medical records. The degree of T-cell infiltration and expression of all markers differed significantly among the molecular subtypes, being highest in non-luminal, more aggressive tumors: more T-cell infiltration and higher expression of all markers were associated with hormone receptor negativity, higher proliferation and higher histological grades, but also with larger tumor size. Basal-like tumors, and most remarkably their tumor centers, hosted the highest number of FoxP3+ T-cells with an unfavorable ratio to cytotoxic CD8+ T-cells. T-cell infiltration was generally higher in the invasive margin than the tumor center. A scoring system based on densities of CD3 and CD8 could significantly separate molecular subtypes (p < 0.001). Thus, immunological patterns with functional implications within each subtype are associated with prognostic factors. These findings should be further validated in studies using larger patient populations and longer follow-up.
         datePublished:2016-07-29T00:00:00Z
         dateModified:2016-07-29T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12967-016-0983-9
         keywords:
            Breast neoplasms
            Cytotoxic T-lymphocytes
            Regulatory T-lymphocytes
            Tumor-infiltrating lymphocytes
            Molecular subtypes
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-016-0983-9/MediaObjects/12967_2016_983_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-016-0983-9/MediaObjects/12967_2016_983_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-016-0983-9/MediaObjects/12967_2016_983_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-016-0983-9/MediaObjects/12967_2016_983_Fig4_HTML.gif
         isPartOf:
            name:Journal of Translational Medicine
            issn:
               1479-5876
            volumeNumber:14
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:M. Miyan
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Schmidt-Mende
               affiliation:
                     name:Karolinska Institutet and Karolinska University Hospital
                     address:
                        name:Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Karolinska University Hospital
                     address:
                        name:Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Kiessling
               affiliation:
                     name:Karolinska Institutet and Karolinska University Hospital
                     address:
                        name:Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:I. Poschke
               affiliation:
                     name:German Cancer Research Center
                     address:
                        name:Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. de Boniface
               url:http://orcid.org/0000-0001-9518-0902
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Karolinska University Hospital
                     address:
                        name:Department of Breast and Endocrine Surgery, P9:03, Karolinska University Hospital, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer
      description:Molecular subtypes of breast cancer and presence of tumor-infiltrating immune cells have both been implicated as important predictive and prognostic factors for improved risk stratification and treatment individualization of breast cancer patients. Their association, however, has not been studied in detail. The aim of this study was to evaluate the expression of the T cell markers CD8, FoxP3, CD3 and ζ-chain in molecular subtypes of the invasive margin and tumor center of breast cancer and corresponding sentinel nodes and to deduct prognostic information from these findings. Tumor and sentinel node sections from 177 patients with primary, invasive, unilateral early-stage breast cancer were stained by immunohistochemistry and T-cell phenotypes quantified manually. Clinical data were collected from medical records. The degree of T-cell infiltration and expression of all markers differed significantly among the molecular subtypes, being highest in non-luminal, more aggressive tumors: more T-cell infiltration and higher expression of all markers were associated with hormone receptor negativity, higher proliferation and higher histological grades, but also with larger tumor size. Basal-like tumors, and most remarkably their tumor centers, hosted the highest number of FoxP3+ T-cells with an unfavorable ratio to cytotoxic CD8+ T-cells. T-cell infiltration was generally higher in the invasive margin than the tumor center. A scoring system based on densities of CD3 and CD8 could significantly separate molecular subtypes (p < 0.001). Thus, immunological patterns with functional implications within each subtype are associated with prognostic factors. These findings should be further validated in studies using larger patient populations and longer follow-up.
      datePublished:2016-07-29T00:00:00Z
      dateModified:2016-07-29T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12967-016-0983-9
      keywords:
         Breast neoplasms
         Cytotoxic T-lymphocytes
         Regulatory T-lymphocytes
         Tumor-infiltrating lymphocytes
         Molecular subtypes
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-016-0983-9/MediaObjects/12967_2016_983_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-016-0983-9/MediaObjects/12967_2016_983_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-016-0983-9/MediaObjects/12967_2016_983_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-016-0983-9/MediaObjects/12967_2016_983_Fig4_HTML.gif
      isPartOf:
         name:Journal of Translational Medicine
         issn:
            1479-5876
         volumeNumber:14
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:M. Miyan
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Schmidt-Mende
            affiliation:
                  name:Karolinska Institutet and Karolinska University Hospital
                  address:
                     name:Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Karolinska University Hospital
                  address:
                     name:Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Kiessling
            affiliation:
                  name:Karolinska Institutet and Karolinska University Hospital
                  address:
                     name:Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:I. Poschke
            affiliation:
                  name:German Cancer Research Center
                  address:
                     name:Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. de Boniface
            url:http://orcid.org/0000-0001-9518-0902
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Karolinska University Hospital
                  address:
                     name:Department of Breast and Endocrine Surgery, P9:03, Karolinska University Hospital, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Translational Medicine
      issn:
         1479-5876
      volumeNumber:14
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Karolinska Institutet
      address:
         name:Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet and Karolinska University Hospital
      address:
         name:Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska University Hospital
      address:
         name:Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet and Karolinska University Hospital
      address:
         name:Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
         type:PostalAddress
      name:German Cancer Research Center
      address:
         name:Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center, Heidelberg, Germany
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska University Hospital
      address:
         name:Department of Breast and Endocrine Surgery, P9:03, Karolinska University Hospital, Stockholm, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:M. Miyan
      affiliation:
            name:Karolinska Institutet
            address:
               name:Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:J. Schmidt-Mende
      affiliation:
            name:Karolinska Institutet and Karolinska University Hospital
            address:
               name:Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
               type:PostalAddress
            type:Organization
            name:Karolinska University Hospital
            address:
               name:Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:R. Kiessling
      affiliation:
            name:Karolinska Institutet and Karolinska University Hospital
            address:
               name:Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:I. Poschke
      affiliation:
            name:German Cancer Research Center
            address:
               name:Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:J. de Boniface
      url:http://orcid.org/0000-0001-9518-0902
      affiliation:
            name:Karolinska Institutet
            address:
               name:Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
            name:Karolinska University Hospital
            address:
               name:Department of Breast and Endocrine Surgery, P9:03, Karolinska University Hospital, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
      name:Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
      name:Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
      name:Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
      name:Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center, Heidelberg, Germany
      name:Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
      name:Department of Breast and Endocrine Surgery, P9:03, Karolinska University Hospital, Stockholm, Sweden

External Links {🔗}(159)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Foundation
Prism.js

CDN Services {📦}

Crossref

5.1s.

LINK . SPRINGER . COM {}